Cargando…

Trajectories of CKD-MBD biochemical parameters over a 2-year period following diagnosis of secondary hyperparathyroidism: a pharmacoepidemiological study

OBJECTIVES: To define groups of patients according to the changes of biochemical parameters, that is, serum calcium, phosphate and parathyroid hormone (PTH), over a 2-year follow-up period using group-based multi-trajectory modeling (GBMM) among a cohort of dialysis patients with newly diagnosed sec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filipozzi, Pierre, Ayav, Carole, Ngueyon Sime, Willy, Laurain, Emmanuelle, Kessler, Michèle, Brunaud, Laurent, Frimat, Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Renal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372074/ https://www.ncbi.nlm.nih.gov/pubmed/28348181 http://dx.doi.org/10.1136/bmjopen-2016-011482

Ejemplares similares

Targets for parathyroid hormone in secondary hyperparathyroidism: is a “one-size-fits-all” approach appropriate? A prospective incident cohort study
por: Laurain, Emmanuelle, et al.
Publicado: (2014)

CKD-MBD diagnosis: biochemical abnormalities
por: Lucca, Leandro Junior, et al.
Publicado: (2021)

Prevention and Treatment of CKD-MBD
por: Cozzolino, Mario
Publicado: (2013)

Predialysis therapeutic care and health-related quality of life at dialysis onset (The pharmacoepidemiologic AVENIR study)
por: Boini, Stephanie, et al.
Publicado: (2011)

The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study
por: Stengel, Bénédicte, et al.
Publicado: (2014)

Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study
por: Lioufas, Nicole, et al.
Publicado: (2019)

CKD-MBD after kidney transplantation
por: Wesseling-Perry, Katherine, et al.
Publicado: (2011)

A Japanese approach for CKD-MBD
por: Yokoyama, Keitaro, et al.
Publicado: (2013)

The Role of Vitamin K in CKD-MBD
por: Fusaro, Maria, et al.
Publicado: (2022)

A cross-sectional study measuring vanadium and chromium levels in paediatric patients with CKD
por: Filler, Guido, et al.
Publicado: (2017)

New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology
por: Bellasi, Antonio, et al.
Publicado: (2019)

Impact of quality improvement initiatives to improve CKD referral patterns: a systematic review protocol
por: Ghimire, Anukul, et al.
Publicado: (2022)

Characteristics, management and outcomes in patients with CKD in a healthcare region in Sweden: a population-based, observational study
por: Agvall, Björn, et al.
Publicado: (2023)

Impact of home telemonitoring and management support on blood pressure control in non-dialysis CKD: a systematic review protocol
por: Okpechi, Ikechi G, et al.
Publicado: (2021)

Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting
por: O'Callaghan, Christopher A, et al.
Publicado: (2011)

Association of serum alkaline phosphatase with mortality in non-selected European patients with CKD5D: an observational, three-centre survival analysis
por: Beige, Joachim, et al.
Publicado: (2014)

Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial
por: Ng, Khai P, et al.
Publicado: (2016)

Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study
por: Ayav, Carole, et al.
Publicado: (2016)

Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study
por: Tangri, Navdeep, et al.
Publicado: (2023)

Clinical significance of parathyroid intervention on CKD-MBD management
por: Ogata, Hiroaki, et al.
Publicado: (2008)

Integrating Conservative kidney management Options and advance care Planning Education (COPE) into routine CKD care: a protocol for a pilot randomised controlled trial
por: Stallings, Taylor L, et al.
Publicado: (2021)

Association between practice coding of chronic kidney disease (CKD) in primary care and subsequent hospitalisations and death: a cohort analysis using national audit data
por: Cleary, Faye, et al.
Publicado: (2022)

Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol
por: Mutatiri, Clyson, et al.
Publicado: (2022)

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients
por: Couchoud, Cécile, et al.
Publicado: (2020)

The EX-FRAIL CKD trial: a study protocol for a pilot randomised controlled trial of a home-based EXercise programme for pre-frail and FRAIL, older adults with Chronic Kidney Disease
por: Nixon, Andrew Christopher, et al.
Publicado: (2020)

Treatment decision-making and care among older adults with kidney failure: protocol for a multicentre, prospective observational cohort study with nested substudies and linked qualitative research (the Elderly Advanced CKD Programme)
por: Siriwardana, Amanda, et al.
Publicado: (2022)

Gaps between Global Guidelines and Local Practices in CKD-MBD
por: Kim, Gheun-Ho
Publicado: (2014)

Which Vitamin D in CKD-MBD? The Time of Burning Questions
por: Galassi, Andrea, et al.
Publicado: (2013)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

CKD-MBD in Brazil: the gap between reality and the recommended guidelines
por: Custódio, Melani Ribeiro
Publicado: (2018)

Diagnosis of bone abnormalities in CKD-MBD (Imaging and bone biopsy)
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2021)

Can patiromer allow for intensified renin–angiotensin–aldosterone system blockade with losartan and spironolactone leading to decreased albuminuria in patients with chronic kidney disease, albuminuria and hyperkalaemia? An open-label randomised controlled trial: MorphCKD
por: Mårup, Frederik Husum, et al.
Publicado: (2022)

Inflammatory Response to Sorbent Hemodialysis
por: Rosales, Laura, et al.
Publicado: (2015)

Dietary sodium induces a redistribution of the tubular metabolic workload
por: Udwan, Khalil, et al.
Publicado: (2017)

VEGF‐A(165)b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF‐A splice isoforms from the kidney
por: Stevens, Megan, et al.
Publicado: (2017)

RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition
por: Koszegi, Sandor, et al.
Publicado: (2018)

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
por: Yamada, Shunsuke, et al.
Publicado: (2023)

Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
por: Rroji, Merita, et al.
Publicado: (2020)

Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
por: Wetmore, James B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l2tmt52ckfqf77ek44de8c82pd